Concepedia
Statistics
Publications
8
Citations
1.3K
H-Index
Active since
2008
Affiliations
ChemoCentryx (United States)(Current)
Karolinska Institutet
Linköping University
University of Cambridge
Charité - Universitätsmedizin Berlin
István Szombati is an author at ChemoCentryx (United States) specializing in pharmacotherapy, rheumatology, and pharmacology.
Publications per year
2008–2023
Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis
David Jayne, Annette Bruchfeld, Lorraine Harper et al. · Journal of the American Society of Nephrology · 2017 · 600 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +15
Analgesic Efficacy and Safety of Oxycodone in Combination With Naloxone as Prolonged Release Tablets in Patients With Moderate to Severe Chronic Pain
Dana Vondráčková, Petra Leyendecker, Michael Hopp et al. · Journal of Pain · 2008 · 211 citations
Nursing, Pharmacology, Pharmacotherapy +15
Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2)
Frank Buttgereit, Daksha Mehta, John Kirwan et al. · Annals of the Rheumatic Diseases · 2013 · 185 citations · Full text
Medicine, Internal Medicine, Pharmacotherapy +13
Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis
Gerd R Burmester, Michael E. Weinblatt, Iain B. McInnes et al. · Annals of the Rheumatic Diseases · 2012 · 158 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +16
Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan
Frank B. Cortazar, John L. Niles, David Jayne et al. · Kidney International Reports · 2023 · 85 citations · Full text
Medicine, Internal Medicine, Nephrology +16
1–5 of 8